Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Recombinant human follicle stimulating hormone - Shanghai Jingze Biotechnology

Next Previous
Drug Profile

Recombinant human follicle stimulating hormone - Shanghai Jingze Biotechnology

Alternative Names: JZB 30

Latest Information Update: 19 Dec 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Shanghai Jingze Biotechnology
  • Class Follicle stimulating hormones; Infertility therapies; Pituitary gonadotropins
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Preregistration Female infertility
  • Preclinical Oligospermia

Most Recent Events

  • 19 Dec 2025 Preclinical trials in Oligospermia in China (Parenteral) prior to December 2025 (Shanghai Jingze Biotechnology pipeline, December 2025)
  • 10 Jan 2023 Preregistration for Female infertility in China (Parenteral) prior to January 2023
  • 13 Sep 2022 JZB 30 is available for licensing as of 23 Aug 2022. https://jingzepharma.com/en/coop.html

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top